A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX

NCT00494221 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: AZD2171
DRUG: FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin)
DRUG: Placebo Cediranib

Sponsor

AstraZeneca